The Limited Times

Now you can see non-English news...

Allegations against corona vaccine study by Biontech: experts give the all clear

2021-11-04T13:42:39.685Z


One whistleblower's allegations about the Biontech / Pfizer vaccine study are long - but shouldn't be too alarming.


One whistleblower's allegations about the Biontech / Pfizer vaccine study are long - but shouldn't be too alarming.

Incorrectly labeled samples, incorrectly stored vaccine, slow reactions to side effects: Despite allegations of sloppiness in the decisive study on the corona vaccine * by Biontech and Pfizer

, experts do not see the effectiveness of the agent in question

.

The information in the specialist magazine "

The BMJ

" about irregularities and errors is not sufficient "to doubt the quality of the clinical study by Biontech / Pfizer," said Peter Kremsner, Director of the Institute for Tropical Medicine at the University of Tübingen.

Whistleblower reports shortcomings in the vaccine study

The background is information from a whistleblower (whistleblower) to “

The BMJ

”: The woman had worked for a subcontractor in autumn 2020 that carried out part of the study on the corona vaccine, which is now used worldwide, on behalf of Pfizer.

She accused her former employer of generating incorrect vaccination data

because, among other things, laboratory samples were incorrectly labeled, the vaccine was incorrectly stored and reports of side effects * were only followed up slowly.

"What the whistleblower has uncovered is without question unpleasant,"

says expert Kremsner.

But it is not enough to generally question the vaccination dates.

“That's just not enough for me.

The vaccination dates have already been confirmed in numerous studies. ”If mistakes were made, the great pressure to succeed and time in the pandemic could have played a role.

"The risk that a subcontractor might not meet the quality standards of the major clinical sponsor can increase in such a case."

More on the topic:

What patients with Long Covid should do against symptoms - new guideline published

Allegations affect only 2.3 percent of the 44,000 participants

Oliver Cornely, scientific director of the Center for Clinical Studies in Cologne, has a similar opinion.

"The

errors described

in"

The BMJ "article do not limit the validity of the vaccine registration study

," he explains.

The subcontractor's investigation centers also looked after only 2.3 percent of the 44,000 participants in the study.

also read

Protection of the Constitution: Institute for state policy right-wing extremists

An AfD-affiliated think tank in Saxony-Anhalt is "secured" right-wing extremists, according to the state's protection of the constitution.

According to observers, the institute is also building bridges to conservatism.

Protection of the Constitution: Institute for state policy right-wing extremists

"House of the Dragon": When will the "Game of Thrones" prequel air?

"Game of Thrones" fans have been waiting for news about "House of the Dragon" for a long time.

Now the first teaser has been published.

"House of the Dragon": When will the "Game of Thrones" prequel air?

"Mess": Delivery service Gorillas terminates a number of striking drivers without notice

The dispute over better working conditions at the delivery service start-up Gorillas seems to have escalated.

There were dozens of layoffs without notice.

"Mess": Delivery service Gorillas terminates a number of striking drivers without notice

And last but not least, the hospitals show how well the vaccines work every day:

"We hardly take inpatients who have been vaccinated because of Covid-19, so we recognize the effectiveness every day," continues Cornely. Despite everything, an official inspection of all centers of the subcontractor is urgently needed.

Biontech wants to investigate reports from the USA about irregularities in a study on the corona vaccine produced together with partner Pfizer.

"

Careful implementation and data collection in clinical studies has the highest priority for Biontech,

" said a spokeswoman for the Mainz-based company of the German Press Agency.

"We take statements such as those made in the article seriously and check them immediately after we have seen them."

(Dpa) * Merkur.de is an offer from IPPEN.MEDIA.

Source: merkur

All life articles on 2021-11-04

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.